Business
Burcon announces publication of Puratein(R) toxicology study
VANCOUVER, Aug. 20 /CNW/ - Burcon NutraScience Corporation (TSX - BU) ("Burcon" or the "Corporati...
About this update from Burcon Nutrascience Corporation
[{"type":"text","content":"\n\n\n\nVANCOUVER, Aug. 20 /CNW/ - Burcon NutraScience Corporation (TSX - BU)\n("Burcon" or the "Corporation") announced today the acceptance for publication\nof a peer-reviewed manuscript describing a toxicology study of Puratein(R)\ncanola protein isolate. The toxicology study was originally conducted to\nestablish the safety of Puratein(R) canola protein isolate in food and\nbeverage applications and ultimately to support the process of obtaining\nGenerally Recognized As Safe status ("GRAS status") for Puratein(R) in the\nUnited States. The manuscript, titled "A 13-week sub-chronic dietary toxicity\nstudy of a cruciferin-rich canola protein isolate in rats", has been accepted\nfor publication in the journal of Food and Chemical Toxicology. Publication of\nthis study is an important step in the process of obtaining GRAS notification\nfor Burcon's Puratein(R) canola protein isolate.\n\n\nThe consumption of canola/rapeseed products in the Western world is\nrecent and has been limited to the use of the oil for cooking and in salads\nand as canola meal in the livestock industry. Burcon's technological advances\nhave made possible the production of canola protein isolates suitable for\nhuman consumption as ingredients in higher amounts and in a broader range of\nfoods. Besides their inherent nutritional value and low levels of\nanti-nutritional factors, Burcon's protein isolates possess unique functional\nproperties such as emulsifying and binding characteristics and transparency\nwhen added to beverages. Burcon's two canola protein isolates are rich in\neither cruciferin or napin, the major canola protein components.\n\n\nThe objective of this study was to evaluate the safety of Puratein(R) (a\ncruciferin-rich canola protein isolate) when fed as a protein source at\nvarious dietary levels to rats for 13-weeks. Luis Mejia, director of\nscientific and regulatory affairs of Archer Daniels Midland Company ("ADM"),\nis the primary author of the study. As previously disclosed, the results of\nthe trial confirmed that Burcon's Puratein(R) canola protein isolate - as\nproduced using Burcon's patented technology - is safe for it's intended use in\nfood and beverage applications,\n\n\n"With the publication of this study we are another step closer to having\nour canola protein isolates G...